Opposing roles of miR-21 and miR-29 in the progression of fibrosis in Duchenne muscular dystrophy

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1852, Issue 7, 2015, Pages 1451-1464

  Zanotti, Simona ^a   Gibertini, Sara ^a   Curcio, Maurizio ^a   Savadori, Paolo ^a   Pasanisi, Barbara ^a   Morandi, Lucia ^a   Cornelio, Ferdinando ^a   Mantegazza, Renato ^a   Mora, Marina ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Duchenne muscular dystrophy; Fibroblast; Fibrosis; Mdx mouse; MiR 21; MiR 29; Myoblast

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 6; MICRORNA; MICRORNA 21; MICRORNA 29; MICRORNA 29A; MICRORNA 29C; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; SPROUTY HOMOLOG 1; SPROUTY PROTEIN; TRANSCRIPTION FACTOR YY1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; COL6A1 PROTEIN, MOUSE; COLLAGEN TYPE I; COLLAGEN TYPE I, ALPHA 1 CHAIN; COLLAGEN TYPE VI; FIBRILLIN; MEMBRANE PROTEINS; MICROFILAMENT PROTEINS; MICRORNAS; MIRN21 MICRORNA, MOUSE; MIRN29 MICRORNA, MOUSE; PHOSPHOPROTEINS; PTEN PHOSPHOHYDROLASE; RNA, MESSENGER; SPRY1 PROTEIN, MOUSE; YY1 PROTEIN, MOUSE; YY1 TRANSCRIPTION FACTOR;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DIAPHRAGM MUSCLE; DISEASE COURSE; DUCHENNE MUSCULAR DYSTROPHY; FIBROBLAST; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; INVESTIGATIVE PROCEDURES; MOUSE; MUSCLE BIOPSY; MYOBLAST; MYOFIBROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMALS; CASE-CONTROL STUDIES; CELLS, CULTURED; CHILD, PRESCHOOL; FIBROBLASTS; FIBROSIS; GENETICS; HUMANS; INFANT; METABOLISM; MICE; MICE, INBRED MDX; MUSCULAR DYSTROPHY, DUCHENNE; MYOBLASTS; PATHOLOGY;

MUS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CASE-CONTROL STUDIES; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; COLLAGEN TYPE I; COLLAGEN TYPE VI; FIBROBLASTS; FIBROSIS; HUMANS; INFANT; MEMBRANE PROTEINS; MICE; MICE, INBRED MDX; MICROFILAMENT PROTEINS; MICRORNAS; MUSCULAR DYSTROPHY, DUCHENNE; MYOBLASTS; PHOSPHOPROTEINS; PTEN PHOSPHOHYDROLASE; RNA, MESSENGER; YY1 TRANSCRIPTION FACTOR;

EID: 84928404190     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2015.04.013     Document Type: Article

References (61)

1. Adam O., Löhfelm B., Thum T., Gupta S.K., Puhl S.L., Schäfers H.J., et al. Role of miR-21 in the pathogenesis of atrial fibrosis. Basic Res. Cardiol. 2012, 107:278.
2. Aoki F., Kojima I. Therapeutic potential of follistatin to promote tissue regeneration and prevent tissue fibrosis. Endocr. J. 2007, 54:849-854.
3. Ardite E., Perdiguero E., Vidal B., Gutarra S., Serrano A.L., Muñoz-Cánoves P. PAI-1-regulated miR-21 defines a novel age-associated fibrogenic pathway in muscular dystrophy. J. Cell Biol. 2012, 196:163-175.
4. Bernasconi P., Torchiana E., Confalonieri P., Brugnoni R., Barresi R., Mora M., et al. Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine. J. Clin. Invest. 1995, 96:1137-1144.
5. Bowen T., Jenkins R.H., Fraser D.J. MicroRNAs, transforming growth factor beta-1, and tissue fibrosis. J. Pathol. 2013, 229:274-285.
6. Brønnum H., Andersen D.C., Schneider M., Sandberg M.B., Eskildsen T., Nielsen S.B., et al. MiR-21 promotes fibrogenic epithelial-to-mesenchymal transition of epicardial mesothelial cells involving Programmed Cell Death 4 and Sprouty-1. PLoS One 2013, 8:e56280.
7. Bujor A.M., Pannu J., Bu S., Smith E.A., Muise-Helmericks R.C., Trojanowska M. Akt blockade downregulates collagen and upregulates MMP1 in human dermal fibroblasts. J. Invest. Dermatol. 2008, 128:1906-1914.
8. Cordani N., Pisa V., Pozzi L., Sciorati C., Clementi E. Nitric oxide controls fat deposition in dystrophic skeletal muscle by regulating fibro-adipogenic precursor differentiation. Stem Cells 2014, 32:874-885.
9. Cushing L., Kuang P.P., Qian J., Shao F., Wu J., Little F., et al. MiR-29 is a major regulator of genes associated with pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 2011, 45:287-294.
10. Desmoulière A., Geinoz A., Gabbiani F., Gabbiani G. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J. Cell Biol. 1993, 122:103-111.
11. Deveaud C.M., Macarak E.J., Kucich U., Ewalt D.H., Abrams W.R., Howard P.S. Molecular analysis of collagens in bladder fibrosis. J. Urol. 1998, 160:1518-1527.
12. Glowacki F., Savary G., Gnemmi V., Buob D., Van der Hauwaert C., Lo-Guidice J.M., et al. Increased circulating miR-21 levels are associated with kidney fibrosis. PLoS One 2013, 8:e58014.
13. Gibertini S., Zanotti S., Savadori P., Curcio M., Saredi S., Salerno F., et al. Fibrosis and inflammation are greater in muscles of beta-sarcoglycan-null mouse than mdx mouse. Cell Tissue Res. 2014, 356:427-443.
14. Grueter C.E., van Rooij E., Johnson B.A., DeLeon S.M., Sutherland L.B., et al. A cardiac microRNA governs systemic energy homeostasis by regulation of MED13. Cell 2012, 149:671-683.
15. Haslett J.N., Sanoudou D., Kho A.T., Bennett R.R., Greenberg S.A., Kohane I.S., et al. Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:15000-15005.
16. He Y., Huang C., Lin X., Li J. MicroR-29 family, a crucial therapeutic target for fibrosis diseases. Biochimie 2013, 95:1355-1359.
17. He Z., Deng Y., Li W., Chen Y., Xing S., Zhao X., et al. Overexpression of PTEN suppresses lipopolysaccharide-induced lung fibroblast proliferation, differentiation and collagen secretion through inhibition of the PI3-K-Akt-GSK3beta pathway. Cell Biosci. 2014, 4:2.
18. Henricson E.K., Abresch R.T., Cnaan A., Hu F., Duong T., Arrieta A., et al. The cooperative international neuromuscular research group Duchenne natural history study: glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing and other commonly used clinical trial outcome measures. Muscle Nerve 2013, 48:55-67.
19. Hubmacher D., Apte S.S. The biology of the extracellular matrix: novel insights. Curr Opin Rheumatol 2013; 25: 65-70. Increased expression of extracellular matrix proteins and decreased expression of matrix proteases after serial passage of glomerular mesangial cells. J. Cell Sci. 1996, 109:2521-2528.
20. Kossakowska A.E., Edwards D.R., Lee S.S., Urbanski L.S., Stabbler A.L., Zhang C.L., et al. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis. Am. J. Pathol. 1998, 153:1895-1902.
21. Kriegel A.J., Liu Y., Fang Y., Ding X., Liang M. The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury. Physiol. Genomics 2012, 44:237-244.
22. Li Y.Y., McTiernan C.F., Feldman A.M. Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. Cardiovasc. Res. 2000, 46:214-224.
23. Liu G., Friggeri A., Yang Y., Milosevic J., Ding Q., Thannickal V.J., et al. MiR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J. Exp. Med. 2010, 207:1589-1597.
24. Lu Y., Azad N., Wang L., Iyer A.K., Castranova V., Jiang B.H., et al. Phosphatidylinositol-3-kinase/akt regulates bleomycin-induced fibroblast proliferation and collagen production. Am. J. Respir. Cell Mol. Biol. 2010, 42:432-441.
25. Maegdefessel L., Azuma J., Toh R., Deng A., Merk D.R., Raiesdana A., et al. MicroRNA-21 blocks abdominal aortic aneurysm development and nicotine-augmented expansion. Sci. Transl. Med. 2012, 4:22ra22.
26. Mann C.J., Perdiguero E., Kharraz Y., Aguilar S., Pessina P., Serrano A.L., et al. Aberrant repair and fibrosis development in skeletal muscle. Skelet. Muscle 2011, 1:21.
27. Medina P.P., Nolde M., Slack F.J. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 2010, 467:86-90.
28. Meng F., Henson R., Wehbe-Janek H., Ghoshal K., Jacob S.T., Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007, 133:647-658.
29. Micallef L., Vedrenne N., Billet F., Coulomb B., Darby I.A., Desmoulière A. The myofibroblast, multiple origins for major roles in normal and pathological tissue repair. Fibrogenesis Tissue Repair 2012, (Suppl. 1):S5.
30. Montgomery R.L., Yu G., Latimer P.A., Stack C., Robinson K., Dalby C.M., et al. MicroRNA mimicry blocks pulmonary fibrosis. EMBO Mol. Med. 2014, 6:1347-1356.
31. Nho R.S., Xia H., Diebold D., Kahm J., Kleidon J., White E., et al. PTEN regulates fibroblast elimination during collagen matrix contraction. J. Biol. Chem. 2006, 281:33291-33301.
32. Noetel A., Kwiecinski M., Elfimova N., Huang J., Odenthal M. MicroRNA are central players in anti- and profibrotic gene regulation during liver fibrosis. Front. Physiol. 2012, 3:49. 10.3389/fphys.2012.00049.
33. Parapuram S.K., Shi-wen X., Elliott C., Welch I.D., Jones H., Baron M., et al. Loss of PTEN expression by dermal fibroblasts causes skin fibrosis. J. Invest. Dermatol. 2011, 131:1996-2003.
34. Patel V., Noureddine L. MicroRNAs and fibrosis. Curr. Opin. Nephrol. Hypertens. 2012, 21:410-416.
35. Pencheva N., Tran H., Buss C., Huh D., Drobnjak M., Busam K., Tavazoie S.F. Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis. Cell 2012, 151:1068-1082.
36. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29:e45.
37. Roderburg C., Urban G.W., Bettermann K., Vucur M., Zimmermann H., Schmidt S., et al. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 2011, 53:209-218.
38. Roy S., Khanna S., Hussain S.R., Biswas S., Azad A., Rink C., et al. MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc. Res. 2009, 82:21-29.
39. Schnaper H.W., Kopp J.B., Poncelet A.C., Hubchak S.C., Stetler-Stevenson W.G., Klotman P.E., et al. Increased expression of extracellular matrix proteins and decreased expression of matrix proteases after serial passage of glomerular mesangial cells. J. Cell Sci. 1996, 109:2521-2528.
40. Selman M., King T.E., Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann. Intern. Med. 2001, 134:136-151.
41. Stephens H.R., Duance V.C., Dunn M.J., Bailey A.J., Dubowitz V. Collagen types in neuromuscular diseases. J. Neurol. Sci. 1982, 53:45-62.
42. Tamby M.C., Chanseaud Y., Guillevin L., Mouthon L. New insights into the pathogenesis of systemic sclerosis. Autoimmun. Rev. 2003, 2:152-157.
43. Thum T., Gross C., Fiedler J., Fischer T., Kissler S., Bussen M., et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008, 456:980-984.
44. Van Rooij E., Sutherland L.B., Thatcher J.E., DiMaio J.M., Naseem R.H., Marshall W.S., et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:13027-13032.
45. Varga J., Pasche B. Transforming growth factor beta as a therapeutic target in systemic sclerosis. Nat. Rev. Rheumatol. 2009, 5:200-206.
46. Wang H., Garzon R., Sun H., Ladner K.J., Singh R., Dahlman J., et al. NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell 2008, 14:369-381.
47. Wang L., Zhou L., Jiang P., Lu L., Chen X., Lan H., et al. Loss of miR-29 in myoblasts contributes to dystrophic muscle pathogenesis. Mol. Ther. 2012, 20:1222-1233.
48. Wang T., Feng Y., Sun H., Zhang L., Hao L., Shi C., et al. MiR-21 regulates skin wound healing by targeting multiple aspects of the healing process. Am. J. Pathol. 2012, 181:1911-1920.
49. Wang X.H., Hu Z., Klein J.D., Zhang L., Fang F., Mitch W.E. Decreased miR-29 suppresses myogenesis in CKD. J. Am. Soc. Nephrol. 2011, 22:2068-2076.
50. Wei J., Feng L., Li Z., Xu G., Fan X. MicroRNA-21 activates hepatic stellate cells via PTEN/Akt signaling. Biomed. Pharmacother. 2013, 67:387-392.
51. Yamada K.M., Araki M. Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis. J. Cell Sci. 2001, 114:2375-2382.
52. Yang X., Wang J., Guo S.L., Fan K.J., Li J., Wang Y.L., et al. MiR-21 promotes keratinocyte migration and re-epithelialization during wound healing. Int. J. Biol. Sci. 2011, 7:685-690.
53. Yao Q., Cao S., Li C., Mengesha A., Kong B., Wei M. Micro-RNA-21 regulates TGF-β-induced myofibroblast differentiation by targeting PDCD4 in tumor-stroma interaction. Int. J. Cancer 2011, 128:1783-1792.
54. Zanotti S., Gibertini S., Bragato C., Mantegazza R., Morandi L., Mora M. Fibroblasts from the muscles of Duchenne muscular dystrophy patients are resistant to cell detachment apoptosis. Exp. Cell Res. 2011, 317:2536-2547.
55. Zanotti S., Gibertini S., Mora M. Altered production of extra-cellular matrix components by muscle-derived Duchenne muscular dystrophy fibroblasts before and after TGF-beta 1 treatment. Cell Tissue Res. 2010, 339:397-410.
56. Zanotti S., Gibertini S., Savadori P., Mantegazza R., Mora M. Duchenne muscular dystrophy fibroblast nodules: a cell-based assay for screening anti-fibrotic agents. Cell Tissue Res. 2013, 352:659-670.
57. Zanotti S., Negri T., Cappelletti C., Bernasconi P., Canioni E., Di Blasi C., et al. Decorin and biglycan expression is differentially altered in several muscular dystrophies. Brain 2005, 128:2546-2555.
58. Zanotti S., Saredi S., Ruggieri A., Fabbri M., Blasevich F., Romaggi S., et al. Altered extracellular matrix transcript expression and protein modulation in primary Duchenne muscular dystrophy myotubes. Matrix Biol. 2007, 26:615-624.
59. Zhou L., Wang L., Lu L., Jiang P., Sun H., Wang H. Inhibition of miR-29 by TGF-beta-Smad3 signaling through dual mechanisms promotes transdifferentiation of mouse myoblasts into myofibroblasts. PLoS One 2012, 7:e33766.
60. Zhu J., Li Y., Shen W., Qiao C., Ambrosio F., Lavasani M., et al. Relationships between transforming growth factor-beta1, myostatin, and decorin: implications for skeletal muscle fibrosis. J. Biol. Chem. 2007, 282:25852-25863.
61. Zanotti S., Gibertini S., Di Blasi C., Cappelletti C., Bernasconi P., Mantegazza R., et al. Osteopontin is highly expressed in severely dystrophic muscle and seems to play a role in muscle regeneration and fibrosis. Histopathology 2011, 59:1215-1228.